Seattle Genetics today announced FDA approval for its drug Tukysa, also known as tucatinib, which fights aggressive breast cancers. Tucatinib… Read More
Updated below with details from news conference. Early results from a first-of-its-kind at-home testing program for COVID-19, analyzing more than… Read More
Based on simulations of the coronavirus outbreak’s future course, Harvard scientists say prolonged or intermittent social distancing may be necessary… Read More
Seattle biotech company Blaze Bioscience has received Fast Track designation from the FDA for a clinical program evaluating tozuleristide. Update, April 8: Blaze… Read More